Skip to content

Cognitive-Behavioral Therapy (CBT) in Children With Diabetes

Assessment of a Cognitive-behavioral Group Intervention in Children With Diabetes Mellitus and Their Parents

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02839031
Acronym
DI-CO
Enrollment
57
Registered
2016-07-20
Start date
2015-03-11
Completion date
2018-07-01
Last updated
2019-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 1

Keywords

diabetes mellitus, glycaemia, cognitive-behavioral treatment, coping, parents, children

Brief summary

Diabetes mellitus in children and adolescents is a source of stress and poor quality of life for themselves and their family. Development of adaptive coping strategies may be improved by focused parent and children training. This study assesses a cognitive behavioral treatment (CBT) for children/adolescents with diabetes and their parents in comparison with standard health educational interventions. The investigators main aim is to verify that the CBT program improves overall balance of glycaemia better than phone contact without CBT content (control group). Secondary objectives are expected improvements of health-related quality of life and coping styles in parents and children.

Interventions

BEHAVIORALCBT (Cognitive-Behavioral Therapy)
BEHAVIORALControl (telephonic support without CBT content)

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Children and teenagers from 6 years-old to 18 years-old * Having diabetes treated by insulin for at least 1 year * Followed in pediatric diabetology department of Arnaud de Villeneuve Hospital in University Hospital of Montpellier * Study Inform Consent signed by both children and parents

Exclusion criteria

* Children with developmental delay, severe mental disorders or language delay * Non French-speaking family * Children who does not live with at least one of his/her parents * Children whose residence is not compatible with frequent visits at University Hospital of Montpellier * Clinical status not compatible with study questionnaires assessment.

Design outcomes

Primary

MeasureTime frame
Glycated hemoglobin (HbA1c) levelup to 12 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026